7-ethyl-10-hydroxycamptothecin Completed Phase 1 Trials for Advanced Solid Tumors / Metastatic Triple Negative Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs